Sangamo Shares Plunge as Pfizer Exits Partnership

Sangamo Therapeutics' stock plummeted by over 50% following Pfizer's decision to withdraw from their joint agreement. Explore the impact on biotech stocks.

A dramatic stock market graph with a steep decline, set against a backdrop of Sangamo and Pfizer log
Sangamo Shares Plunge as Pfizer Exits Partnership

Sangamo Therapeutics shares decreased over 50% after Pfizer exited their collaborative agreement.

Source